Freedom Investment Management’s Inovio Pharmaceuticals INO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $33.3K | Sell |
16,387
-2,783
| -15% | -$5.66K | ﹤0.01% | 727 |
|
|
2025
Q1 | $31.2K | Buy |
+19,170
| New | +$31.2K | ﹤0.01% | 731 |
|
|
2023
Q4 | – | Sell |
-5,192
| Closed | -$24.2K | – | 770 |
|
|
2023
Q3 | $24.2K | Buy |
5,192
+3,105
| +149% | +$14.5K | ﹤0.01% | 664 |
|
|
2023
Q2 | $11.2K | Sell |
2,087
-122
| -6% | -$654 | ﹤0.01% | 697 |
|
|
2023
Q1 | $21.7K | Sell |
2,209
-73
| -3% | -$718 | ﹤0.01% | 695 |
|
|
2022
Q4 | $42.7K | Sell |
2,282
-66
| -3% | -$1.24K | ﹤0.01% | 695 |
|
|
2022
Q3 | $48.6K | Sell |
2,348
-151
| -6% | -$3.13K | 0.01% | 707 |
|
|
2022
Q2 | $51.9K | Buy |
2,499
+551
| +28% | +$11.4K | 0.01% | 711 |
|
|
2022
Q1 | $84K | Sell |
1,948
-138
| -7% | -$5.95K | 0.01% | 751 |
|
|
2021
Q4 | $125K | Sell |
2,086
-55
| -3% | -$3.3K | 0.01% | 831 |
|
|
2021
Q3 | $184K | Sell |
2,141
-91
| -4% | -$7.82K | 0.01% | 775 |
|
|
2021
Q2 | $248K | Buy |
2,232
+420
| +23% | +$46.7K | 0.02% | 760 |
|
|
2021
Q1 | $202K | Buy |
+1,812
| New | +$202K | 0.02% | 788 |
|